A review of Mendelian randomization in amyotrophic lateral sclerosis is a research paper published in Brain (2021). On theSindex it has a DataRank of 0. It has been cited 79 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CEGS 5P50HG00773504, 1P50HL083800, 1R01HL101388, 1R01-HL122939, S10OD025212, P30DK116074, and UM1HG009442 to M.P.S.
Wellcome Trust
Grant: 216596/Z/19/Z to J.C.-K.
NIHR
Grant: NF-SI-0617–10077 to P.J.S.
NIHR Sheffield Biomedical Research Centre for Translational Neuroscience
Grant: IS-BRC1215-20017
NHLBI NIH HHS
Grant: P50 HL083800
National Institute for Health Research (NIHR)
Grant: ACF-2021-04-008
Motor Neurone Disease Association
Grant: Cooper-Knock/Oct20/899-792
NHLBI NIH HHS
Grant: R01 HL122939
NIDDK NIH HHS
Grant: P30 DK116074
NHGRI NIH HHS
Grant: UM1 HG009442
NIH HHS
Grant: S10 OD025212
National Institute for Health Research (NIHR)
Grant: NF-SI-0617-10077
NHLBI NIH HHS
Grant: R01 HL101388
Wellcome Trust
Grant: 216596/Z/19/Z
Wellcome Trust
Grant: 216596
Identifying and verifying non-coding genetic causes of amyotrophic lateral sclerosis
National Institutes of Health
Grant: 5R01HL101388-04
DNA Variants and AAA Disease
National Institutes of Health
Grant: 5P30DK116074-04
Stanford Diabetes Research Center
National Institutes of Health
Grant: 1S10OD025212-01
Ultra high throughput sequencer for sustaining and enhancing multi-scale genomic studies
National Institutes of Health
Grant: 5P50HL083800-04
AAA Disease: Mechanism, Stratification and Treatment
National Institutes of Health
Grant: 5R01HL122939-02
MicroRNA Regulation of Nicotine Accelerated AAAs
National Institutes of Health
Grant: 5UM1HG009442-04
PRODUCTION CENTER FOR MAPPING REGULATORY REGIONS OF THE HUMAN GENOME
Wellcome Trust
National Institute for Health Research (NIHR)
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Exploring the causal role of the immune response to varicella-zoster virus on multiple traits: a phenome-wide Mendelian randomization study
Additional file 1 of Exploring the causal role of the immune response to varicella-zoster virus on multiple traits: a phenome-wide Mendelian randomization study
Additional file 3 of Exploring the causal role of the immune response to varicella-zoster virus on multiple traits: a phenome-wide Mendelian randomization study
Additional file 3 of Exploring the causal role of the immune response to varicella-zoster virus on multiple traits: a phenome-wide Mendelian randomization study
Additional file 1 of Large-scale genome-wide association studies reveal the genetic causal etiology between air pollutants and autoimmune diseases
Additional file 1 of Large-scale genome-wide association studies reveal the genetic causal etiology between air pollutants and autoimmune diseases
Additional file 8 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 9 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 9 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 7 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 8 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 7 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 3 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 5 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 4 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 5 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 6 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 3 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 4 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES
Additional file 6 of The Impact of Blood and Urine Biomarkers on Age-Related Macular Degeneration: Insights from Mendelian Randomization and Cross-sectional Study from NHANES